Study guide
8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness)
NABP MPJE Multistate Pharmacy Jurisprudence Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pharmacist Licensure & Reciprocity
1.1 Initial Licensure Requirements & Examinations 1.2 License Renewal, Continuing Education (CE) & Status 1.3 Reciprocity, License Transfer & Multistate Licensure 1.4 Disciplinary Actions, Board Hearings, Sanctions & Reinstatement
2 Chapter 2: Pharmacy Personnel Roles & Supervision Ratios
2.1 Pharmacy Interns: Scope of Practice, Supervision & Preceptor Rules 2.2 Pharmacy Technicians: Registration, Certification & Permitted Duties 2.3 Technician-to-Pharmacist Ratios & Delegated Tasks 2.4 Non-Pharmacist Personnel & Automated Dispensing Technology Roles
3 Chapter 3: Prescriptive Authority & Practitioner Categories
3.1 Physicians, Dentists, Veterinarians & Podiatrists: Prescribing Scope 3.2 Mid-Level Practitioners: APNs, PAs, Optometrists & Independent Authority 3.3 Out-of-State, Foreign & Deceased Practitioner Prescriptions 3.4 Self-Prescribing & Prescribing for Family Members
4 Chapter 4: Patient Counseling & Drug Utilization Review (OBRA '90)
4.1 OBRA '90 Mandates & Prospective Drug Utilization Review (DUR) 4.2 Patient Counseling Requirements, Offer-to-Counsel & Documentation 4.3 Patient Profile Requirements & Retrospective DUR
5 Chapter 5: Advanced Pharmacist Practice & Collaborative Agreements
5.1 Collaborative Practice Agreements (CPAs) & Protocol-Based Care 5.2 Pharmacist Immunization Authority & Vaccine Administration Protocols 5.3 Medication Therapy Management (MTM) & Point-of-Care Testing (POCT) 5.4 Hormonal Contraceptive, Naloxone & Post-Exposure Prophylaxis (PEP/PrEP) Prescribing
6 Chapter 6: Federal Controlled Substances Act (CSA) & Scheduling
6.1 Controlled Substance Schedules (CI through CV) & Classification Criteria 6.2 DEA Registration: Types, Forms (224, 225, 363) & Renewal Cycles 6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)
7 Chapter 7: Controlled Substance Prescriptions & Legitimate Purpose
7.1 Corresponding Responsibility & Red Flags for Improper Prescribing 7.2 Required Components of Controlled Substance Prescriptions 7.3 Electronic Prescriptions for Controlled Substances (EPCS) & Security Requirements 7.4 Emergency Schedule II Prescriptions & Partial Filling Rules (CARA Act)
8 Chapter 8: Controlled Substance Ordering, Inventory & Recordkeeping
8.1 Ordering Schedule II Substances: CSOS & DEA Form 222 Execution 8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness) 8.3 Theft, Significant Loss (DEA Form 106) & Disposal/Destruction (DEA Form 41) 8.4 Prescription Transfers & Prescription Drug Monitoring Programs (PDMPs)
9 Chapter 9: Federal Pure Food, Drug & Cosmetic Act (FD&C Act) & Drug Safety
9.1 Adulteration vs. Misbranding: Statutory Definitions & Legal Violations 9.2 Prescription Labeling Requirements, Expiration Dates & Side Effect Statements 9.3 Poison Prevention Packaging Act (PPPA) & Child-Resistant Container Exemptions 9.4 Drug Recalls (Class I, II, III) & Market Withdrawals 9.5 Drug Product Selection, Generic Substitution & DAW Codes 9.6 Returning & Reusing Dispensed Drugs: Restocking, Redispensing & Repository Programs
10 Chapter 10: Drug Supply Chain Security Act (DSCSA) & Commercial Distribution
10.1 DSCSA Track-and-Trace Requirements: Transaction Information & Statements 10.2 Suspect & Illegitimate Product Verification, Quarantine & Notification 10.3 Prescription Drug Marketing Act (PDMA): Samples, Reimportation & Wholesale Distribution
11 Chapter 11: Compounding Standards: USP <795>, <797> & <800>
11.1 Section 503A vs. 503B Compounding Facilities (DQSA Architecture) 11.2 Non-Sterile Compounding (USP <795>) & Beyond-Use Dating (BUD) 11.3 Sterile Compounding (USP <797>): Air Quality, Cleanrooms & BUD 11.4 Hazardous Drug Handling (USP <800>): Engineering Controls & Personal Protective Equipment
12 Chapter 12: Pharmacy Operational Security, Records & Telepharmacy
12.1 Physical Pharmacy Security, Alarm Systems & Keyholder Rules 12.2 Mandatory Pharmacy Records Retention & Audit Inspection Readiness 12.3 Central Fill, Automated Dispensing Systems (ADS) & Telepharmacy Operations 12.4 HIPAA Privacy Rule, Patient Records & Breach Notification Protocols
8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness)
Key Takeaways Explain This Topic AI
An initial controlled substance inventory must be conducted on the first day a pharmacy opens for business.
A biennial inventory is required at least every 2 years and must record whether counts were taken at Opening of Business (AOB) or Close of Business (COB).
Exact physical counts are required for all Schedule I and Schedule II controlled substances.
For Schedule III, IV, and V drugs, an estimated count is allowed for open containers of 1,000 units or less, but an exact count is required if the container holds >1,000 units.
When a drug is newly scheduled by the DEA, stock must be inventoried on the effective date, and Schedule II inventory records must be kept separately.
Last updated: July 2026
8.2 Controlled Substance Inventory Requirements (Initial, Biennial, Count Exactness)
A fundamental element of DEA oversight and accountability under the Controlled Substances Act (CSA) is the mandatory controlled substance inventory . Inventories serve as the legal accounting baseline against which all receipts, distributions, and dispensings are audited. Regulations governing inventory taking, frequency, count exactness, and recordkeeping are codified in 21 CFR § 1304.11 .
Initial Inventory Requirements
Before a pharmacy opens for business or begins handling controlled substances under a new DEA registration, an Initial Inventory must be conducted.
Key Initial Inventory Mandates:
Timing : Conducted on the first day the pharmacy opens for business or handles controlled substances.
Zero Stock Rule : Even if the pharmacy has zero controlled substances in stock on day one, an initial inventory document must be completed reflecting a zero count .
Required Elements : The record must state the date, time of day (Opening of Business [AOB] or Close of Business [COB]), pharmacy name, DEA registration number, address, and signature of the person(s) taking the inventory.
Biennial Inventory Requirements
Following the initial inventory, every DEA registrant must conduct a complete controlled substance inventory at least every two years (biennially) .
Timing & Frequency Rules:
2-Year Window : The biennial inventory can be taken on any date within two years of the previous inventory date .
AOB vs. COB Mandate : The inventory record must explicitly state whether the count was performed at the Opening of Business (AOB) or Close of Business (COB) on the specified inventory date. This distinction ensures precise transaction matching for drugs dispensed or received on that calendar date.
State Specifics : Many states mandate annual (every 1 year) inventories rather than federal biennial (every 2 years) inventories. Pharmacists must adhere to the stricter state requirement for compliance, but federal law sets the baseline at 2 years.
Newly Scheduled Drugs
When a previously non-controlled drug is placed into any controlled substance schedule (Schedules I through V) by the DEA, or when a controlled drug is reclassified to a higher schedule:
Every registrant in possession of that drug must take an inventory of all on-hand stock of that specific substance on the effective date of scheduling .
This newly scheduled inventory record is retained alongside existing inventory records and incorporated into future biennial inventories.
Count Exactness Rules: Exact vs. Estimated Counts
Federal law establishes strict standards regarding whether a pharmacist must perform an exact physical count or may use an estimated count during an inventory. The count exactness rule depends on the controlled substance schedule and the original commercial container size .
Controlled Substance Schedule Original Container Package Size Physical Count Requirement
Schedule I & Schedule II (CI - CII) Any container size (open or unopened) EXACT Count (or exact measure for liquids/powders)
Schedule III, IV, & V (CIII - CV) Unopened commercial containers EXACT Count (based on labeled container content)
Schedule III, IV, & V (CIII - CV) Open containers holding 1,000 units or fewer (e.g., 100, 500, 1,000 count bottles) ESTIMATED Count permitted
Schedule III, IV, & V (CIII - CV) Open containers holding MORE THAN 1,000 units (e.g., 5,000 count stock bottles) EXACT Count required
Deep Dive into the 1,000-Unit Threshold
On the MPJE, a common trap involves open bottles of Schedule III-V medications. If an open stock bottle of alprazolam 1 mg originally held 1,000 tablets , the pharmacist may estimate the count. However, if the open bottle originally held 1,001 or more tablets (e.g., a bulk container of 5,000 tablets), an exact physical count is required by federal law.
Required Content of Inventory Records
Every controlled substance inventory record maintained by a pharmacy must contain the following mandatory data fields:
Date the inventory was taken.
Time of day executed: Explicitly marked as Opening of Business (AOB) or Close of Business (COB) .
Drug Name : Generic or brand name.
Dosage Form and Strength : (e.g., Oxycodone 10 mg tablet, Fentanyl 25 mcg/hr patch).
Number of Commercial Containers : (e.g., 3 unopened bottles, 1 opened bottle).
Quantity/Count per Container : Exact count for CIIs and large CIII-CV containers; estimated count for small CIII-CV open containers.
Total Quantity : Sum of units on hand.
Administrative Details : Pharmacy name, address, DEA number, and recommended signature of the pharmacist conducting the inventory.
Storage, Maintenance, and Retention Rules
Retention Period : Inventory records must be maintained for a minimum of 2 years from the date of execution under federal law (21 CFR § 1304.04). State law may require 3 to 5 years.
Separation of Schedule II Records : Inventory records for Schedule II controlled substances must be kept completely separate from all other pharmacy records.
Schedule III-V Records : Records for Schedule III, IV, and V substances may be kept separately or maintained in such a form that they are readily retrievable (e.g., stamped with a red 'C' if interfiled, or accessible via distinct computer code).
Central Recordkeeping Exclusions : While the DEA permits central storage for certain financial and shipping records, controlled substance inventories CANNOT be stored at a central location —they must be kept physically at the registered pharmacy location.